Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eyebright Medical is a China-based ophthalmic medical device company focused on products for cataract surgery, myopia management, and consumer vision care. The company develops, manufactures, and commercializes intraocular lenses, orthokeratology lenses, soft contact lenses, capsular tension rings, and related ophthalmic surgical and optometric products. It is publicly traded on the STAR Market of the Shanghai Stock Exchange and has built a broad commercial portfolio rather than a drug-development pipeline. Eyebright appears to be an active, revenue-generating healthcare company with significant operations in China and expanding international ambitions. Its business is centered on ophthalmic devices and vision products rather than biotech therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyebright Medical.